LAGHI PASINI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 10.064
EU - Europa 8.177
AS - Asia 1.892
SA - Sud America 278
AF - Africa 53
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 20.492
Nazione #
US - Stati Uniti d'America 10.018
GB - Regno Unito 2.399
IE - Irlanda 1.382
CN - Cina 1.082
SE - Svezia 832
UA - Ucraina 812
IT - Italia 710
DE - Germania 614
RU - Federazione Russa 568
SG - Singapore 519
FR - Francia 419
BR - Brasile 242
FI - Finlandia 234
VN - Vietnam 112
ES - Italia 47
IN - India 43
BE - Belgio 38
CI - Costa d'Avorio 34
CA - Canada 32
TR - Turchia 31
NL - Olanda 26
TH - Thailandia 18
CZ - Repubblica Ceca 17
AT - Austria 15
AU - Australia 13
GR - Grecia 12
EU - Europa 11
MA - Marocco 9
AR - Argentina 7
AZ - Azerbaigian 7
HK - Hong Kong 7
JP - Giappone 7
EC - Ecuador 6
IL - Israele 6
LT - Lituania 6
LV - Lettonia 6
PL - Polonia 6
BG - Bulgaria 5
IQ - Iraq 5
IR - Iran 5
KZ - Kazakistan 5
MX - Messico 5
NP - Nepal 5
PE - Perù 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
HR - Croazia 4
ID - Indonesia 4
PK - Pakistan 4
RS - Serbia 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
JO - Giordania 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
AL - Albania 2
AM - Armenia 2
BD - Bangladesh 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
BN - Brunei Darussalam 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
SM - San Marino 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 20.492
Città #
Southend 2.233
Fairfield 1.488
Dublin 1.353
Ashburn 804
Chandler 734
Woodbridge 691
Jacksonville 642
Wilmington 574
Menlo Park 539
Santa Clara 530
Seattle 525
Houston 515
Cambridge 470
Ann Arbor 397
Siena 316
Princeton 266
Beijing 248
Nanjing 232
Singapore 186
Boardman 117
Dearborn 113
Dong Ket 111
Helsinki 106
New York 96
San Diego 96
San Mateo 92
Nanchang 84
Moscow 62
Shenyang 57
Shanghai 56
Council Bluffs 51
Florence 46
Málaga 46
Tianjin 41
Hebei 40
Venezia 39
Brussels 38
Kunming 37
Milan 35
Abidjan 34
Düsseldorf 32
Jiaxing 31
Lancaster 29
Changsha 27
Jinan 27
Izmir 25
San Francisco 25
Norwalk 24
São Paulo 23
Falls Church 21
London 21
Guangzhou 20
Toronto 20
Hefei 18
Washington 18
Los Angeles 17
Lappeenranta 16
Mestre 16
Munich 16
Redwood City 16
Ningbo 15
Nuremberg 15
Zhengzhou 15
Rome 13
The Dalles 13
Chicago 12
Pune 12
Hangzhou 11
Brno 10
Changchun 10
Fremont 10
Lanzhou 10
Ottawa 10
Caserta 9
Paris 9
Taizhou 9
Hyderabad 8
Tappahannock 8
Baku 7
Dallas 7
Delhi 7
Fuzhou 7
Guarulhos 7
Philadelphia 7
Pisa 7
Rio de Janeiro 7
Hong Kong 6
Hounslow 6
Olomouc 6
Petah Tikva 6
Phoenix 6
Riga 6
Sacramento 6
Vienna 6
Wuhan 6
Amsterdam 5
Auburn Hills 5
Belo Horizonte 5
Buenos Aires 5
Canberra 5
Totale 14.916
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 303
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 284
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 263
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 250
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 246
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 244
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 229
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 225
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 221
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 219
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 218
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 212
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 211
Torsades de Pointes in patients with polymyalgia rheumatica 206
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 199
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 199
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 197
Statins and the joint: multiple targets for a global protection? 195
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 194
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 190
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 189
QTc interval prolongation during infusion with dipyridamole or adenosine 182
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 178
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 176
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 176
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 173
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 170
Connective tissue diseases and cardiac rhythm disorders: an overview 165
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 162
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 161
The role of P2X7 receptors in tissue fibrosis: a brief review 160
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 159
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 159
Heart failure and chronic kidney disease in a registry of internal medicine wards 158
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 156
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 156
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 155
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates 155
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 155
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 155
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 155
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 155
Modulation of P2X7 receptor during inflammation in multiple sclerosis 155
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 154
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 153
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 153
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 152
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 152
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 150
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 150
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 149
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 149
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 148
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 147
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 146
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 146
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 146
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 146
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 146
null 145
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 145
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 145
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 144
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 143
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 143
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 142
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 141
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 140
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 140
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 138
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 137
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 135
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 135
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 134
Homocysteine and Raynaud’s phenomenon: a review 134
Human rheumatoid synoviocytes express functional P2X7 receptors 133
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 133
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 133
Familial Mediterranean fever diagnosed in an elderly patient 131
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 131
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 130
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 129
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 129
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 127
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 127
Pathogenesis of the novel autoimmune-associated long-QT syndrome 126
null 126
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 125
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 124
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 124
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 124
null 122
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 122
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 122
null 122
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 121
Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. 121
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 121
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 120
Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment. 119
Totale 16.040
Categoria #
all - tutte 68.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020696 0 0 0 0 0 0 0 0 0 351 122 223
2020/20212.825 141 306 93 284 146 348 111 375 287 262 230 242
2021/20222.075 147 273 129 173 135 58 103 105 113 180 206 453
2022/20232.706 168 243 394 385 245 546 70 191 289 64 61 50
2023/20242.205 98 31 168 103 103 632 720 57 22 51 55 165
2024/20252.329 74 207 350 248 514 238 131 216 317 34 0 0
Totale 20.764